image description

Category: News

LRA Announces Partners on the First Anniversary of the Lupus Landmark Study

The Lupus Research Alliance (LRA) and its clinical research affiliate Lupus Therapeutics (LT) are pleased to announce the group of industry partners working together on the implementation of the Lupus Nexus. The Lupus Nexus, one of LRA’s most ambitious and groundbreaking endeavors, is a first-of-its-kind lupus registry, biorepository, and data exchange platform that aims to […] Read More

Meet Unstoppable Advocate for Minority Health Christopher Reed

Determined to alleviate healthcare disparities for minorities, J. Christopher Reed, JD, urges our lupus community to use the power of National Minority Health Month to spotlight the issue this April. First diagnosed at 16, Christopher fought debilitating lupus symptoms to graduate college in eight years and then Tulane University Law School in three. Throughout college […] Read More

Lupus Peer-to-Peer Early Education Program Expands

Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, has announced an innovative expansion of the highly successful Patient Advocates for Lupus Studies (PALS) program with the introduction of a first-in-lupus “Trial Buddy” component made possible by a partnership with Bristol Myers Squibb. The Trial Buddy addition provides extra support to people with […] Read More

Congress Passes Budget With $10M for Lupus Research Program

Congress and passed and President Biden signed the 2024 spending bills, which include priorities that you, our advocates requested last March.  The Defense Appropriations bill includes $10 million for the Lupus Research Program within the Department of Defense.  And the Agriculture-FDA bill includes a provision expressing support for FDA’s engagement with industry and the lupus […] Read More

Recent Discoveries Shedding Light on Why Women Are at a Greater Risk for Lupus

Lupus is a complex autoimmune disease affecting millions worldwide with a staggering gender imbalance — about 9 of 10 people with lupus are women. Underlying biological, hormonal, or environmental factors likely contribute to why lupus affects females more often. Understanding why women are at greater risk for lupus could unlock novel treatments and revolutionize outcomes […] Read More

Lupus Therapeutics Announces Collaboration to Support the Evaluation of Non-Genetically Modified Cell-Based Therapy for Lupus Nephritis with Artiva Biotherapeutics

Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, announced a collaboration with Artiva Biotherapeutics, Inc. on a Phase 1 trial of the company novel NK cell-based therapy AlloNK® (also known as AB-101), in combination with anti-CD20 antibodies, for patients with active lupus nephritis – inflammation of the kidneys caused by lupus. AlloNK […] Read More

Lupus Research Alliance Announces Recipients of the Lupus Mechanisms and Targets Award

The Lupus Research Alliance (LRA) is pleased to announce the recent recipients of the Lupus Mechanisms and Targets Award (LMTA), whose research will investigate molecular pathways or targets that will lead to new or improved therapies for individuals with systemic lupus erythematosus (SLE). The LMTA provides investigators up to $600,000 over three years. The development […] Read More

Embracing the Arts to Educate and Advocate

In honor of Black History Month, we bring you the story of eloquent poet performer and lupus advocate Shanelle Gabriel.  With a focus on the theme “African Americans and the Arts,” Black History Month is a perfect time to hear from Shanelle, a woman who uses her poetry and music to elevate the voices of […] Read More

Re-engineering Immune Cells Opens Door to Promising Therapy for Lupus Kidney Inflammation

Research featured in Nature Communications highlights a novel approach that re-engineers a person’s own immune cells to suppress the overactive immune system that occurs in lupus nephritis, a serious and potentially life-threatening inflammation of the kidneys. With funding in part from the Lupus Research Alliance (LRA), associate professor Joshua Ooi, Ph.D. and his team at the […] Read More

Lupus Research Alliance 2023 Dr. William E. Paul Distinguished Innovator Award Granted to Yale School of Medicine Researcher Akiko Iwasaki, Ph.D.

Research Will Explore How Ancient Viral Remnants in Our DNA Trigger Lupus The Lupus Research Alliance (LRA) is pleased to grant the 2023 Dr. William E. Paul Distinguished Innovator Award (DIA) to Akiko Iwasaki, Ph.D., Sterling Professor of Immunobiology at the Yale School of Medicine. Dr. Iwasaki will investigate a possible cause of lupus – […] Read More